Gemcitabine and Erlotinib

DRUG2 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University, Grupo Espanol Multidisciplinario del Cancer Digestivo

Conditions

Metastatic Pancreatic CancerPancreatic Adenocarcinoma

Phase 1

Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer

CompletedNCT00954525

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityMetastatic Pancreatic Cancer

Start: 2009-07-31End: 2011-12-31Updated: 2025-05-02

Phase 2

Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer

CompletedNCT01389440

Grupo Espanol Multidisciplinario del Cancer DigestivoPancreatic Adenocarcinoma

Start: 2011-05-31End: 2017-01-22Updated: 2018-05-18

Related Papers

Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).

2018-09-178 citations

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

2012-01-17188 citations